The U.S. International Trade Commission ruled in 2023 that Apple violated a Masimo patent and had to stop importing its ...

Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

As it turned out, Masimo beat all but three of the patent infringement claims brought by Apple at the conclusion of a five-day federal jury trial and the judgment will not affect Masimo's sales at ...

It's been more than a year since Apple Watch Ultra 2 launched, and we've had the wearable that's only gotten better on our ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Unrecognized Contract Revenues: $1.65 billion as of the end of Q3. Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for the third quarter, representing a 12% growth compared ...

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on reducing spending to drive long-term growth. The company continues to evaluate ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...

In 2014, Dunlop won a famous case involving breast cancer tests where competitor Myriad Genetics claimed it could patent ...

The patent, filed by Apple under number 12133743, sheds light on how sensors could be integrated into fabric-based bands for the Apple Watch. These bands would be comfortable to wear around the ...